Istituti Tumori Giovanni Paolo II
14
2
2
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 14 trials
100.0%
+13.5% vs industry average
7%
1 trials in Phase 3/4
0%
0 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
Upfront Surgery Versus NeoAdjuvant Chemotherapy Followed by Surgery for Resectable Advanced Gastric Cancer: SNAC Study
Role: collaborator
PRO Survivorship Concerns ITA
Role: collaborator
Analysis of HPV and Biomarkers Present in the Biological Fluids of Patients Suffering From Head and Neck Cancer as a Non-invasive Strategy for Detecting Recurrence
Role: collaborator
GENomic PROfilation for Therapeutic Purposes in SARComas and Molecular Tumor Board (MTB): Retrospective/Prospective Study in Referral Centers
Role: collaborator
Establishment of the Human Intestinal and Salivary Microbiota Biobank - Obesity
Role: collaborator
Intra-Operative Electron Boost and Hypofractionated Whole-Breast Irradiation During Breast-conserving Treatment (BCT)
Role: collaborator
Establishment of the Human Intestinal and Salivary Microbiota Biobank - Gastrointestinal Diseases
Role: collaborator
Establishment of the Human Intestinal and Salivary Microbiota Biobank - Oncologic Diseases
Role: collaborator
Establishment of the Human Intestinal and Salivary Microbiota Biobank - Gynecological Diseases
Role: collaborator
Establishment of the Human Intestinal and Salivary Microbiota Biobank - Kidney Diseases
Role: collaborator
Establishment of the Human Intestinal and Salivary Microbiota Biobank - Metabolic Syndrome
Role: collaborator
Establishment of the Human Intestinal and Salivary Microbiota Biobank- Diabetes
Role: collaborator
Hypercoagulation Screening in Cancer
Role: collaborator
Gemcitabine or Gemcitabine and Cisplatin in the Treatment of Advanced Pancreatic Cancer
Role: lead
All 14 trials loaded